Berlin - Delayed Quote EUR

Chemical Works of Gedeon Richter PLC (RIG2.BE)

Compare
25.16 -0.14 (-0.55%)
As of 8:04:09 AM GMT+1. Market Open.
Currency in HUF All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
811,415,000.00
--
802,755,000.00
630,595,000.00
566,776,000.00
Cost of Revenue
254,427,000.00
--
342,291,000.00
281,322,000.00
248,006,000.00
Gross Profit
556,988,000.00
--
460,464,000.00
349,273,000.00
318,770,000.00
Operating Expense
336,419,000.00
--
308,473,000.00
213,759,000.00
205,010,000.00
Operating Income
220,569,000.00
--
151,991,000.00
135,514,000.00
113,760,000.00
Net Non Operating Interest Income Expense
43,221,000.00
--
-10,449,000.00
6,056,000.00
-999,000.00
Pretax Income
255,315,000.00
--
165,663,000.00
146,575,000.00
115,164,000.00
Tax Provision
24,902,000.00
--
-5,087,000.00
5,395,000.00
9,112,000.00
Net Income Common Stockholders
229,129,000.00
--
169,076,000.00
139,626,000.00
104,683,000.00
Diluted NI Available to Com Stockholders
229,129,000.00
--
169,076,000.00
139,626,000.00
104,683,000.00
Basic EPS
1.25k
860.00
907.00
751.00
563.00
Diluted EPS
1.25k
860.00
907.00
751.00
563.00
Basic Average Shares
183,118.02
184,769.00
186,333.00
186,008.00
185,971.00
Diluted Average Shares
183,118.02
184,769.00
186,333.00
186,008.00
185,971.00
Total Operating Income as Reported
138,113,000.00
--
153,555,000.00
135,832,000.00
115,089,000.00
Total Expenses
590,846,000.00
--
650,764,000.00
495,081,000.00
453,016,000.00
Net Income from Continuing & Discontinued Operation
229,129,000.00
--
169,076,000.00
139,626,000.00
104,683,000.00
Normalized Income
235,224,252.54
--
180,657,570.00
141,171,924.61
105,766,096.00
Interest Income
21,899,000.00
--
13,418,000.00
2,950,000.00
915,000.00
Interest Expense
14,424,000.00
--
8,030,000.00
663,000.00
631,000.00
Net Interest Income
43,221,000.00
--
-10,449,000.00
6,056,000.00
-999,000.00
EBIT
269,739,000.00
--
173,693,000.00
147,238,000.00
115,795,000.00
EBITDA
319,389,000.00
--
222,262,000.00
192,160,000.00
155,641,000.00
Reconciled Cost of Revenue
254,427,000.00
--
342,291,000.00
281,322,000.00
248,006,000.00
Reconciled Depreciation
49,650,000.00
--
48,569,000.00
44,922,000.00
39,846,000.00
Net Income from Continuing Operation Net Minority Interest
229,129,000.00
--
169,076,000.00
139,626,000.00
104,683,000.00
Total Unusual Items Excluding Goodwill
-6,754,000.00
--
-12,727,000.00
-1,605,000.00
-1,176,000.00
Total Unusual Items
-6,754,000.00
--
-12,727,000.00
-1,605,000.00
-1,176,000.00
Normalized EBITDA
326,143,000.00
--
234,989,000.00
193,765,000.00
156,817,000.00
Tax Rate for Calcs
0.00
--
0.00
0.00
0.00
Tax Effect of Unusual Items
-658,747.46
--
-1,145,430.00
-59,075.39
-92,904.00
12/31/2020 - 7/14/2003

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

29A.SG Amphastar Pharmaceuticals Inc
34.66
-0.14%
 
068760.KQ Celltrion Pharm, Inc.
56,900.00
-1.22%
 
27N0.DU Cannovum Cannabis AG
0.5000
+0.40%
 
0ET.MU Esperion Therapeutics Inc
2.1410
0.00%
 
CRFTF BC Craft Supply Co. Ltd.
0.0001
0.00%
 
11L.MU Canopy Growth Corp. R
2.5700
-0.39%
 
R9U2.F Green Thumb Industries Inc.
7.42
+2.77%
 
KN0.F Dicot Pharma AB
0.0282
+20.00%
 
CEL.L Celadon Pharmaceuticals Plc
14.00
-12.50%
 
9989.HK Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
3.640
-2.93%